Aflac 3rd Quarter 2026 Earnings Call - AFLAC INC

Explicit Guidance:

• FY 2026 Japan Pre-tax Profit Margin: Raised expected range to 35–38%.
• FY 2026 Japan Benefit Ratio: Expected to be slightly below the 60–63% range.
• FY 2026 Japan Expense Ratio: Expected to be on the lower end of the 20–23% range.
• FY 2026 U.S. Benefit Ratio: Expected to be below the 48–52% range.
• FY 2026 U.S. Expense Ratio: Expected to be in the middle of the 36–39% range.
• FY 2026 U.S. Pre-tax Profit Margin: Expected to be above the 17–20% range.
• FY 2026 Japan Sales: Confirmed expectation to exceed 2025 sales levels.
• FY 2026 U.S. Q4 Outlook: Expectation to be better than Q4 2025 performance, driven by an extra week of productivity.

Business-Segment Outlook:

• Aflac Japan:
  • Product Mix: Planning to significantly grow "First Sector" (savings) business (currently 20% of sales) due to attractive new business IRRs and valuation, leveraging reinsurance to manage capital intensity.
  • Persistency: Expecting to maintain solid levels, despite slight elevation in lapse/reissue activity on new products; lapses on first-sector savings remain low despite rising Japanese interest rates.
  • Sales Recovery: Sales operations fully restored to normal in Q4 after Q3 cyber incident disruptions; October sales aligned with expectations.
  • Capital Release: Estimated $1 billion capital release from the Q3 reinsurance transaction (ceding 500 billion yen to Aflac Bermuda) available for future redeployment.
• Aflac U.S.:
  • Growth Drivers: Momentum expected to continue in Group Life, Disability (including behavioral health), and Network Dental. Dental/Vision platforms grew 67% YoY in the quarter.
  • Synergies: Strategy focuses on bundling voluntary benefits with dental/vision and group life; achieving 90 cents of voluntary benefit sales for every dollar of dental sold.
  • Scale: Deferring acquisition expenses for group life and disability blocks to improve expense ratios as they approach scale.
  • Individual Platform: Currently shrinking (-1.5%); management is actively working to reverse this trend.

Market and Competitive Outlook:

• Japan Market Dynamics:
  • Cancer Insurance: Morito cancer insurance sales remain relatively strong; Japanese consumers continue to prioritize financial protection against cancer.
  • Medical Insurance: "Anshin Pallet" (medical insurance) sales increased year-over-year.
  • First Sector Opportunity: Elevated yen interest rates and competitive returns have driven demand for savings products; management views this as a significant opportunity to capture market share given current capacity.
• U.S. Market Dynamics:
  • Group Disability: Management notes peer pressure regarding behavioral health claims but views their exposure as materially small; anticipates opportunity to gain market share as competitors raise rates.
  • Pricing Power: Strong execution on renewal programs allowing for rate action and profit improvement in group life and disability.

Macro / Industry Outlook:

• Interest Rates (Japan): Rising Japanese interest rates are viewed as favorable for the new business IRR of the First Sector (savings) business.
• Currency (FX): Weak yen increased yen-denominated net investment income via USD assets. Management notes that 64% of debt is in yen, intentionally leveraging FX to protect the economic value of Aflac Japan in USD terms (impacting leverage ratios).
• Healthcare Costs: Ongoing rising healthcare costs in both Japan and the U.S. continue to drive demand for supplemental insurance solutions.
• Cybersecurity: Q3 included $40 million in cybersecurity expenses; future ratios will normalize once this one-time spend is excluded.

Strategic Initiatives:

• Leadership Transition (Effective Jan 1, 2027):
  • Shinsuke Morimoto promoted to President, Aflac Japan.
  • Fred Simard promoted to President, Aflac U.S.
  • Masatoshi Koide assumes Chairman, Aflac Japan.
  • Charles Lake becomes Executive Advisor, Aflac Japan and Chairman, Aflac International.
• Reinsurance Strategy: Internal risk limit for ceding FSA reserves to Aflac Bermuda increased from 10% (U.S. GAAP basis) to 30%. Currently at 15%; significant runway remains to enhance risk composition and ROE.
• Portfolio Rebalancing (JGB Switch Trades): Completed repositioning of $7 billion (including $2.3 billion in Q3) of Japanese Government Bonds to capture higher yields. Future trades depend on balancing reinvestment opportunities against unrealized losses on legacy books; expected to be less linear/frequent than recent activity.
• Capital Deployment: Commitment to continued share repurchases and dividends to maintain high return on capital; specific flexibility in "tactical opportunistic" deployment.

Risks and Headwinds to Outlook:

• Cybersecurity: One-time expenses of $40 million impacted Q3 expense ratios; future outlook assumes no similar magnitude unless new threats emerge.
• Credit Risk: Commercial real estate valuations and middle-market loan performance remain under pressure; ongoing loan reserve boosts are being implemented in private credit portfolios.
• Asset Impairments: Q3 saw $6 million in U.S. statutory impairments on invested assets and mortgage loans; FSA basis saw net realized gains but continued valuation allowances on transitional real estate loans.
• Currency Volatility: Fluctuations in the Yen/USD exchange rate impact reported leverage ratios and pre-tax margins.
• Behavioral Health Claims: While current exposure is low, industry-wide trends in behavioral health claims for group disability remain a monitorable risk factor.
• Switch Trade Complexity: Future portfolio repositioning is constrained by accounting, tax, liquidity, and ALM considerations, with the difficulty of finding new opportunities increasing as the portfolio matures.

Management Tone on the Future:

• Confidence Level: High confidence in the strategy, citing "solid" results, strong persistency, and the ability to offset lapses.
• Strategic Clarity: Management expresses strong conviction in the reinsurance capability as a core tool for capital efficiency and ROE improvement.
• Growth Outlook: Optimistic regarding First Sector growth in Japan (attributed to rate environment and product fit) and Group business momentum in the U.S.
• Hedges/Qualifiers: Acknowledges that First Sector growth is capital intensive and requires monitoring to avoid cost-of-capital erosion; notes that switch trade impacts will diminish over time due to portfolio maturity.

Miscellaneous:

• Dividend History: 44 consecutive years of dividend increases maintained through Q3 2026.
• Capital Return: Returned $1.1 billion to shareholders in Q3 (combining buybacks and dividends) and $3.7 billion YTD.
• Liquidity: Unencumbered liquidity stood at $2.7 billion, $1.7 billion above the $1 billion minimum balance.
• Regulatory Capital: Estimated Regulatory ESR of 225% (rising to 238% with USP); Combined RBC estimated slightly above 575%.
• Investment Income: Variable investment income was $22 million below long-term expectations; net investment income improvements from switch trades are projected to add >$30 million annually.